Big Moments Look Overdone For LeMaitre Vascular, Inc. (LMAT), Camden National Corporation (CAC)
The stocks of LeMaitre Vascular, Inc. (NASDAQ:LMAT) has been Upgraded as a Buy from Hold by Lake Street in its latest research note that was published on October 24. LMAT was given a price target of$40 by Lake Street, with other Wall Street analysts also giving their reports regarding the stock. The stock also received a Strong Buy to Outperform rating from First Analysis Sec with the price target of $37 to $40. This was contained in a research note published by the firm on October 24. The stock received a Outperform to Strong Buy rating and a price target of $37 in First Analysis Sec’s research note that was published on October 14.
LMAT surged by $0.06 during the normal trading session on Monday and reaching a high of $35.63 during the day while it closed the day at $35.37. The LeMait ...